Tran-Dinh, A.; Levoye, A.; Couret, D.; Galle-Treger, L.; Moreau, M.; Delbosc, S.; Hoteit, C.; Montravers, P.; Amarenco, P.; Huby, T.;
et al. High-Density Lipoprotein Therapy in Stroke: Evaluation of Endothelial SR-BI-Dependent Neuroprotective Effects. Int. J. Mol. Sci. 2021, 22, 106.
https://doi.org/10.3390/ijms22010106
AMA Style
Tran-Dinh A, Levoye A, Couret D, Galle-Treger L, Moreau M, Delbosc S, Hoteit C, Montravers P, Amarenco P, Huby T,
et al. High-Density Lipoprotein Therapy in Stroke: Evaluation of Endothelial SR-BI-Dependent Neuroprotective Effects. International Journal of Molecular Sciences. 2021; 22(1):106.
https://doi.org/10.3390/ijms22010106
Chicago/Turabian Style
Tran-Dinh, Alexy, Angélique Levoye, David Couret, Lauriane Galle-Treger, Martine Moreau, Sandrine Delbosc, Camille Hoteit, Philippe Montravers, Pierre Amarenco, Thierry Huby,
and et al. 2021. "High-Density Lipoprotein Therapy in Stroke: Evaluation of Endothelial SR-BI-Dependent Neuroprotective Effects" International Journal of Molecular Sciences 22, no. 1: 106.
https://doi.org/10.3390/ijms22010106
APA Style
Tran-Dinh, A., Levoye, A., Couret, D., Galle-Treger, L., Moreau, M., Delbosc, S., Hoteit, C., Montravers, P., Amarenco, P., Huby, T., & Meilhac, O.
(2021). High-Density Lipoprotein Therapy in Stroke: Evaluation of Endothelial SR-BI-Dependent Neuroprotective Effects. International Journal of Molecular Sciences, 22(1), 106.
https://doi.org/10.3390/ijms22010106